Trial Profile
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Besifovir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Il Dong
- 28 Aug 2018 New trial record